Assyro AI

FDA Orange Book · active-ingredient family

Phenyl aminosalicylate

Phenyl aminosalicylate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:PHENY-PAS-TEBAMIN · NDA 011695

1

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · powder, tablet

ProductApplicantApplicationTEApproved
PHENY-PAS-TEBAMIN×2PHARM RES ASSOCNDA 011695Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Phenyl aminosalicylate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.